Jennifer Quint is a Professor of Respiratory Epidemiology at the National Heart and Lung Institute and Honorary Consultant Physician in Respiratory Medicine at the Royal Brompton and Imperial College London NHS Foundation Trusts.
Dr Quint’s research interests centre on the use of electronic health records to study chronic obstructive pulmonary disease (COPD) as well as other chronic respiratory diseases including asthma, ILD and bronchiectasis. She leads a clinical epidemiology research group whose work centres largely on understanding the relationship between cardiovascular and respiratory disease as well as maximising the quality, linkage and usage of routinely collected data for clinical and research purposes. The majority of her work has been on exacerbations of COPD, exploring both the effect of COPD exacerbations on vascular outcomes and the relationship between environmental factors and exacerbations of COPD.
Whittaker H, Kiddle S, Quint J, 2021, Challenges and pitfalls of using repeat spirometry recordings in routine primary care data to measure FEV1 decline in a COPD population, Pragmatic and Observational Research, ISSN:1179-7266
et al., 2021, The long-term sequelae of COVID-19: an international consensus on research priorities for patients with pre-existing and new-onset airways disease., Lancet Respir Med
et al., 2021, Impact of COVID-19 national lockdown on asthma exacerbations: interrupted time-series analysis of English primary care data, Thorax, Vol:76, ISSN:0040-6376, Pages:860-866
et al., 2021, Under-recognition of heart failure in patients with atrial fibrillation and the impact of gender: a UK population-based cohort study, Bmc Medicine, Vol:19, ISSN:1741-7015
et al., 2021, Characteristics of patients initiating Spiriva Respimat for asthma in the UK, WILEY, Pages:163-163, ISSN:1053-8569